Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE | 74,000 | reported | 06 Feb 2019 | tx 5+250,790 |
| Mineralys Therapeutics, Inc. | 48,538 | reported | 19 Feb 2026 | tx 38+692,621−470,972 |
| VICAL INC | 20,000 | reported | 16 Mar 2020 | tx 1+20,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2026 | GRANT_AWARD | Mineralys Therapeutics, Inc. | 39,900 | 0.00 USD | |
| 19 Feb 2026 | GRANT_AWARD | Mineralys Therapeutics, Inc. | 53,300 | 0.00 USD | deriv |
| 12 Jan 2026 | SALE | Mineralys Therapeutics, Inc. | 10,758 | 32.14 USD | |
| 11 Nov 2025 | EXERCISE | Mineralys Therapeutics, Inc. | 34,414 | 16.00 USD | |
| 11 Nov 2025 | SALE | Mineralys Therapeutics, Inc. | 38,900 | 45.93 USD | |
| 11 Nov 2025 | SALE | Mineralys Therapeutics, Inc. | 8,456 | 45.18 USD | |
| 11 Nov 2025 | SALE | Mineralys Therapeutics, Inc. | 4,142 | 43.50 USD | |
| 11 Nov 2025 | SALE | Mineralys Therapeutics, Inc. | 8,485 | 42.34 USD | |
| 11 Nov 2025 | SALE | Mineralys Therapeutics, Inc. | 12,952 | 41.65 USD | |
| 11 Nov 2025 | SALE | Mineralys Therapeutics, Inc. | 1,561 | 42.68 USD | |
| 11 Nov 2025 | SALE | Mineralys Therapeutics, Inc. | 11,295 | 41.87 USD | |
| 11 Nov 2025 | SALE | Mineralys Therapeutics, Inc. | 1,015 | 42.00 USD | |
| 11 Nov 2025 | EXERCISE | Mineralys Therapeutics, Inc. | 20,547 | 10.20 USD | |
| 11 Nov 2025 | SALE | Mineralys Therapeutics, Inc. | 32,718 | 46.88 USD | |
| 11 Nov 2025 | EXERCISE | Mineralys Therapeutics, Inc. | 44,079 | 14.25 USD | |
| 11 Nov 2025 | EXERCISE | Mineralys Therapeutics, Inc. | 6,613 | 15.44 USD | |
| 11 Nov 2025 | EXERCISE | Mineralys Therapeutics, Inc. | 6,613 | 0.00 USD | deriv |
| 11 Nov 2025 | EXERCISE | Mineralys Therapeutics, Inc. | 44,079 | 0.00 USD | deriv |
| 11 Nov 2025 | EXERCISE | Mineralys Therapeutics, Inc. | 34,414 | 0.00 USD | deriv |
| 11 Nov 2025 | EXERCISE | Mineralys Therapeutics, Inc. | 20,547 | 0.00 USD | deriv |
| 13 Oct 2025 | SALE | Mineralys Therapeutics, Inc. | 7,366 | 41.90 USD | |
| 13 Oct 2025 | SALE | Mineralys Therapeutics, Inc. | 3,392 | 42.26 USD | |
| 30 Jul 2025 | SALE | Mineralys Therapeutics, Inc. | 51,500 | 14.70 USD | |
| 29 Jul 2025 | SALE | Mineralys Therapeutics, Inc. | 807 | 14.00 USD | |
| 28 Jul 2025 | SALE | Mineralys Therapeutics, Inc. | 12,946 | 14.04 USD |
1 purchase reported after at least 12 months of silence — most recent on 14 Feb 2023.